Health · 11 views
First siRNA Therapy Approved for Myasthenia Gravis
(MedPage Today) -- The FDA approved subcutaneous cemdisiran (Livsayis), a small interfering RNA (siRNA) therapy, to treat generalized myasthenia gravis in adults who are anti-acetylcholine receptor (AChR) antibody-positive, Regeneron…
Summary
(MedPage Today) -- The FDA approved subcutaneous cemdisiran (Livsayis), a small interfering RNA (siRNA) therapy, to treat generalized myasthenia gravis in adults who are anti-acetylcholine receptor (AChR) antibody-positive, Regeneron announced
AI summaries can be wrong sometimes—always verify important details using the source article.
How AI & Automation are usedMore from Health
Continue reading recent Health coverage
- Wearable heart monitor moves from lab to clinical trialContinue reading
- ChatGPT's translation of mental health questionnaires into Mandarin reveals inconsistent resultsContinue reading
- International report discusses risks of chemicals in everyday itemsContinue reading
- Outside stressors for military members can cause more medical visitsContinue reading
Support HappeningNow
Independent AI-powered news analysis is reader-supported. Your contribution helps cover infrastructure, summaries, and continued platform development.
Support HappeningNow